Effect of an Online Reimbursement Application System on Prescribing of Lidocaine 5% Medicated Plaster in the Republic of Ireland
Amelia Smith (),
Stephen Doran,
Maria Daly,
Cormac Kennedy and
Michael Barry
Additional contact information
Amelia Smith: Trinity College Dublin, Trinity Centre for Health Sciences, St. James’ Hospital
Stephen Doran: Trinity College Dublin, Trinity Centre for Health Sciences, St. James’ Hospital
Maria Daly: Trinity College Dublin, Trinity Centre for Health Sciences, St. James’ Hospital
Cormac Kennedy: Trinity College Dublin, Trinity Centre for Health Sciences, St. James’ Hospital
Michael Barry: Trinity College Dublin, Trinity Centre for Health Sciences, St. James’ Hospital
Applied Health Economics and Health Policy, 2021, vol. 19, issue 1, No 13, 133-140
Abstract:
Abstract Background The lidocaine 5% medicated plaster, Versatis®, has one therapeutic indication listed on the Summary of Product Characteristics—symptomatic relief of post-herpetic neuralgia (PHN) in adults. Increased expenditure on Versatis® suggests that there is considerable off-label use. To support the appropriate use of Versatis®, the Health Service Executive’s Primary Care Reimbursement Service (PCRS) introduced a reimbursement application system for Versatis® from 1 September 2017. Objective The aim of this study was to investigate the effect of introducing a reimbursement application system on Versatis® prescribing under the General Medical Services (GMS) scheme. Methods This study was carried out using prescription dispensing data from the PCRS pharmacy claims database. We carried out segmented linear regression to assess changes in the Versatis® prescribing rate per 1000 GMS eligible population, before and after the introduction of the online reimbursement application system. Results The results of the segmented regression analysis show that there was a statistically significant level (− 4.91, p
Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations:
Downloads: (external link)
http://link.springer.com/10.1007/s40258-020-00586-5 Abstract (text/html)
Access to the full text of the articles in this series is restricted.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:spr:aphecp:v:19:y:2021:i:1:d:10.1007_s40258-020-00586-5
Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40258
DOI: 10.1007/s40258-020-00586-5
Access Statistics for this article
Applied Health Economics and Health Policy is currently edited by Timothy Wrightson
More articles in Applied Health Economics and Health Policy from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().